(d)

Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Text with EEA relevance) · European Union

provide the ETF with access to external sources of electronic health data to which the Agency has access, including health data generated outside of clinical studies.

← art_20__point_c__text_1 · All articles · art_20__point_d__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.